Paper33248151
Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture.
Tanganelli F and 11 others. Exp Gerontol, 2021. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture. Papers, record 33248151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33248151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hip Fractures | Major topic |
| Sarcopenia | Major topic |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Hand Strength | |
| Humans | |
| Male | |
| Muscle Fibers, Skeletal | |
| Muscle, Skeletal |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857278 | Loss of SREBF1 disrupts lipid signaling and causes slow muscle fiber degeneration. | iScience | 2026 | https://conductscience.org/library/papers/42857278 | PubMed |
| 42829920 | Single-Nucleus Atlas of Spinal Sarcopenia Patients Reveals Disruption of Quiescent and Regenerative Satellite Cell Niches in Fatty-Infiltrated Muscle. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42829920 | PubMed |
| 42666262 | Molecular interaction mechanisms of muscle fiber type transition in aging sarcopenia and the role of exercise intervention. | Egypt J Intern Med | 2026 | https://conductscience.org/library/papers/42666262 | PubMed |
| 41717660 | Tensiomyography-derived contractile parameters in sarcopenic and non-sarcopenic older adults. | Front Aging | 2026 | https://conductscience.org/library/papers/41717660 | PubMed |
| 41686840 | ACE-031, a soluble activin type IIB receptor, increases muscle mass and strength in the common marmoset (Callithrix jacchus). | PLoS One | 2026 | https://conductscience.org/library/papers/41686840 | PubMed |
| 41647509 | Sarcopenia in type 2 diabetes mellitus: an imaging review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41647509 | PubMed |
| 41635016 | Association of Sarcopenia and Lower Bone Density With Positional Vertigo in the Morning: Insights From a Nationwide Survey. | J Cachexia Sarcopenia Muscle | 2026 | https://conductscience.org/library/papers/41635016 | PubMed |
| 41328324 | Negative Impact of p21-Activated Kinase 4-Mediated AMP-Activated Protein Kinase Inhibition on Sarcopenia in Mice and Humans. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41328324 | PubMed |
| 41327924 | Altered Body Composition in Dizziness and Vestibular Dysfunction: Insights From the Korean National Health and Nutrition Examination Survey. | J Korean Med Sci | 2025 | https://conductscience.org/library/papers/41327924 | PubMed |
| 41297061 | Epigenetic aging signatures and age prediction in human skeletal muscle. | Aging (Albany NY) | 2025 | https://conductscience.org/library/papers/41297061 | PubMed |
| 40940786 | Combined Protein, Probiotics, and Exercise Therapy for Sarcopenia: A Comprehensive Review. | Cells | 2025 | https://conductscience.org/library/papers/40940786 | PubMed |
| 40806632 | Protective Efficacy of Lactobacillus plantarum Postbiotic beLP-K in a Dexamethasone-Induced Sarcopenia Model. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806632 | PubMed |
| 40632651 | A mechanistic basis of fast myofiber vulnerability to neuromuscular diseases. | Cell Rep | 2025 | https://conductscience.org/library/papers/40632651 | PubMed |
| 40540722 | Exercise as a Metabolic Regulator: Targeting AMPK/mTOR-Autophagy Crosstalk to Counteract Sarcopenic Obesity. | Aging Dis | 2025 | https://conductscience.org/library/papers/40540722 | PubMed |
| 40438271 | Exploration of Pathogenesis and Cutting-Edge Treatment Strategies of Sarcopenia: A Narrative Review. | Clin Interv Aging | 2025 | https://conductscience.org/library/papers/40438271 | PubMed |
| 40423288 | The Effects of Exercise Intervention in Older Adults With and Without Sarcopenia: A Systematic Review. | Sports (Basel) | 2025 | https://conductscience.org/library/papers/40423288 | PubMed |
| 39739941 | Exploring determinant factors influencing muscle quality and sarcopenia in Bilbao's older adult population through machine learning: A comprehensive analysis approach. | PLoS One | 2024 | https://conductscience.org/library/papers/39739941 | PubMed |
| 39695784 | Type 2 diabetes-related sarcopenia: role of nitric oxide. | Nutr Metab (Lond) | 2024 | https://conductscience.org/library/papers/39695784 | PubMed |
| 39466193 | Relationship between histological findings of vastus lateralis muscle and function after total hip arthroplasty in patients with hip fracture: a prospective cohort study. | Acta Orthop | 2024 | https://conductscience.org/library/papers/39466193 | PubMed |
| 39456222 | Modulation of Carnitine Palmitoyl Transferase 1b Expression and Activity in Muscle Pathophysiology in Osteoarthritis and Osteoporosis. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456222 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33248151
GET https://conductscience.org/api/papers/v1/33248151/cited_by?page=2